Retour
Affymax Inc (AFFY) Gagner
Graphique du cours de l'action AFFY
AFFY Gagner
Affymax Inc
$0
0%
$0
À partir d'aujourd'hui :Mar 24, 14:57:02 GMT-4
Statistiques clés
Clôture préc.
$0.001
Prix d'ouverture
$0.0009
Plage de la journée
$0.0009 - $0.001
Plage de 52 semaines
$0.0001 - $0.003
Volume
6.0K
Volume moyen
15.8K
Rendement en dividend
--
BPA (TTM)
0.07
Capitalisation boursière
$37.4K
Qu’est-ce que AFFY ?
Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
